CJ Rapitest CEA test kit - Taiwan Registration 214a4b3952b7d23a21dcf2e55c78c8ca
Access comprehensive regulatory information for CJ Rapitest CEA test kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 214a4b3952b7d23a21dcf2e55c78c8ca and manufactured by Qizhe Biotechnology Co., Ltd. The authorized representative in Taiwan is Qizhe Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
214a4b3952b7d23a21dcf2e55c78c8ca
Ministry of Health Medical Device Manufacturing No. 005603
Product Details
This product qualitatively detects carcinoembryonic antigen (CEA) in human serum.
C Immunology and microbiology devices
C6010 Tumor-associated antigen immunoassay system
Produced in Taiwan, China
Dates and Status
Apr 21, 2017
Apr 21, 2022